机构:[1]Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, and Collaborative Innovation Center of Cancer Medicine, Guangzhou, China[2]Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China中山大学附属第二医院[3]Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China[4]Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore[5]Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning, China[6]Department of Medical Oncology, Hunan Cancer Hospital, Changsha, China[7]Department of Lymphoma-Oncology, Guizhou Cancer Hospital, Guiyang, Guizhou, China[8]Department of Hematology, Guangdong General Hospital, Guangzhou, China广东省人民医院[9]Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China[10]Department of Medical Oncology, Nanjing General Hospital of Nanjing Military Command, Nanjing, China[11]Department of Lymphoma-Oncology, Peking University Cancer Hospital, Beijing, China[12]Department of Hematology, West China Hospital of Sichuan University, Chengdu, China四川大学华西医院[13]Department of Hematology, Nanfang Hospital of Southern Medical University, Guangzhou, China[14]Department of Radiation Oncology, Wuhan Union Hospital, Wuhan, China华中科技大学同济医学院附属协和医院[15]Department of Medical Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China[16]Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, China浙江省肿瘤医院[17]Department of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China[18]Department of Hematology, the First Affiliated Hospital Zhejiang University, Hangzhou, China浙江大学医学院附属第一医院[19]Department of Hematology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China中山大学附属第一医院[20]Department of Medical Oncology, the First People’s Hospital of Foshan, Foshan, China[21]Department of Medical Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, China[22]Department of Medical Oncology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China中山大学附属第三医院[23]Department of Hematology, Peking University Third Hospital, Beijing, China[24]Department of Medical Oncology, Jiangmen Central Hospital, Jiangmen, China[25]Department of Medical Oncology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China[26]Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Fuzhou, Fujian, China[27]Department of Epidemiology, Sun Yat-sen University Cancer Center, Guangzhou, China[28]Division of Hematology Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
This work is supported by Guangdong Science and Technology Department (grant numbers 2017B020227002 and 2017A020215030). We thank all the patients, their families, and the institutions for supporting this study. We thank the committee on malignant lymphoma from the Chinese Southwest Oncology Group and the Asia Lymphoma Study Group
第一作者机构:[1]Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, and Collaborative Innovation Center of Cancer Medicine, Guangzhou, China[2]Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Huangming Hong,Yexiong Li,Soon Thye Lim,et al.A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group.[J].Leukemia.2020,34(8):2243-2248.doi:10.1038/s41375-020-0740-1.
APA:
Huangming Hong,Yexiong Li,Soon Thye Lim,Chaoyong Liang,He Huang...&Tongyu Lin.(2020).A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group..Leukemia,34,(8)
MLA:
Huangming Hong,et al."A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group.".Leukemia 34..8(2020):2243-2248